GRCE
Grace Therapeutics (GRCE)
$42
About Grace Therapeutics (GRCE)
Grace Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Princeton, NJ.
Details
Daily high
$4.59
Daily low
$4.33
Price at open
$4.53
52 Week High
$4.71
52 Week Low
$1.75
Market cap
68.7M
Dividend yield
0.00%
Volume
323,229
Avg. volume
406,669
P/E ratio
-12.32
Grace Therapeutics News
Details
Daily high
$4.59
Daily low
$4.33
Price at open
$4.53
52 Week High
$4.71
52 Week Low
$1.75
Market cap
68.7M
Dividend yield
0.00%
Volume
323,229
Avg. volume
406,669
P/E ratio
-12.32